Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Flonase, Zaditor DTC Ads Cited By FDA; Both Allergy Campaigns Are Over

Executive Summary

FDA is directing GlaxoSmithKline and Novartis to revise direct-to-consumer ads for allergy products attempting to capitalize on the changes in the market following the OTC switch of Claritin

You may also be interested in...



FDA Invites Manufacturers, Ad Agencies To Discuss DTC Ad Designs

FDA would like to consult with pharmaceutical companies and their advertising agencies early on in the development of direct-to-consumer advertising campaigns

FDA Invites Manufacturers, Ad Agencies To Discuss DTC Ad Designs

FDA would like to consult with pharmaceutical companies and their advertising agencies early on in the development of direct-to-consumer advertising campaigns

DTC Comparative Drug Campaigns To Be Addressed At FDA Public Meeting

Standards for comparative drug claims in direct-to-consumer ads will be one topic for discussion during a Sept. 22-23 FDA public meeting on consumer-directed promotion of prescription drugs

Related Content

UsernamePublicRestriction

Register

LL1129949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel